Microglia degrade Alzheimer's amyloid-beta deposits extracellularly via digestive exophagy

Rudy G Jacquet1, Fernando González Ibáñez2, Katherine Picard2

  • 1Department of Biochemistry, Weill Cornell Medicine, New York, NY 10065, USA.

Cell Reports
|December 7, 2024
PubMed

Insights

Microglia digest large amyloid-beta plaques via digestive exophagy, releasing enzymes into extracellular compartments. This process, modulated by the PI3K-AKT pathway, may paradoxically contribute to plaque growth.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Alzheimer's disease is characterized by amyloid-beta (Aβ) plaques.
  • The mechanism by which microglia digest large, fibrillar Aβ plaques is poorly understood.
  • Phagocytosis is insufficient for clearing large Aβ aggregates.

Purpose of the Study:

  • To elucidate the mechanism of microglial digestion of large amyloid-beta plaques.
  • To investigate the role of extracellular compartments and lysosomal enzymes in Aβ degradation.
  • To identify signaling pathways regulating this process.

Main Methods:

  • Primary microglial cell cultures and model Aβ plaques.
  • Transmission electron microscopy in 5xFAD mouse brains.
  • Signaling pathway inhibition (PI3K-AKT pathway).
  • Analysis of lysosome exocytosis and actin polymerization.

Main Results:

  • Microglia form acidic extracellular compartments, termed lysosomal synapses, to digest Aβ plaques.
  • Digestive exophagy, involving exocytosis of lysosomal enzymes like acid phosphatase, was confirmed in vivo.
  • The PI3K-AKT pathway regulates lysosomal synapse formation by controlling lysosome exocytosis and actin polymerization.
  • Microglia exocytose internalized Aβ fibrils towards larger aggregates, potentially promoting plaque growth.

Conclusions:

  • Microglia employ digestive exophagy to degrade large amyloid-beta plaques.
  • The PI3K-AKT pathway is a key regulator of this microglial degradative process.
  • Digestive exophagy may contribute to the spread and growth of fibrillar Aβ in Alzheimer's disease.